HILLERØD, DENMARK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies, a world-leading contract development ...
HOLLY SPRINGS, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies (the Company), a world leading contract development and manufacturing organization (CDMO) for biologics, ...
Fujifilm's Holly Springs site will be operational next year. Fujifilm Diosynth Biotechnologies will support manufacturing for a Morrisville-based firm's multiple sclerosis treatment at the company ...
The Fujifilm Corporation first announced plans for a £600m investment into operations in Billingham in 2021, where its Fujifilm Diosynth Biotechnologies subsidiary manufactures Novavax ...
Pioneering a global modular network for facility design and drug production HILLERØD, DENMARK - November 6, 2024 — FUJIFILM Diosynth Biotechnologies, a world-leading contract development and ...
HOLLY SPRINGS, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies (the Company), a world leading contract development and manufacturing organization (CDMO) for biologics ...
Holly Springs, North Carolina site to provide security of supply for B-cell therapy for relapsing multiple sclerosis HOLLY SPRINGS, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth ...
HILLERØD, DENMARK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines ...